Tuesday, August 16, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

WILMINGTON, N.C. - Shareholders say Pharmaceutical Product Development is selling itself too cheaply to the Carlyle Group, for $3.9 billion, or $33.25 a share.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.